Red Heart - CNEA

Cardiovascular Pharmacology 2 Day Program

CE Hours: 14.50
Purchase Price: $This course is no longer available for purchase.

Online classes are available for 12 month access.

Presented by: Karen Marzlin and Cynthia Webner 

Save money! CNEA offers a 12 month subscription that includes ALL our online CE courses.  Access to more than 240 CEs for one price. Click here to learn more.

Course Description: 
This newly recorded (2019) 2-day course takes a deep dive into cardiovascular pharmacology used in the management of adult / gerontology patients in all settings of care. Content is presented from the advanced practice provider perspective while including practical application content for both the advanced practice nurse and the nurse at the point of care. Throughout the program you will be engaged with clinical examples and case studies. You will be challenged to apply new knowledge to your own practice.

Course content includes guideline recommendations from the American College of Cardiology and American Heart Association. Key learning points include:  clinical decision making, patient safety, advocacy, pearls for prescribing, and optimal point of care practices are highlighted. Through a patient centered and physiological approach to learning, this program is designed to equip you with knowledge to take your practice to the next level. You will complete this program feeling confident and committed!

Course Content:  
Session 1

  • Impacting Cardiac Output with Pharmacologic Therapy
  • Acute Coronary Syndromes / CAD – Pharmacotherapy for Effective Short-term and Long-term Treatment
  • Hyperlipidemia: Utilizing the New Guidelines to Make Appropriate Pharmacologic Treatment Decisions
  • Diabetes in the Cardiac Patient: Managing the Multiple Pharmacologic Options to Improve Outcomes
  • Pharmacologic Approach to Tobacco Cessation
  • Peripheral Arterial Disease Management – Pharmacologic Approach
  • Patient Considerations in Impacting Adherence to Medication Recommendations

Session 2

  • Antiarrhythmic Pharmacology for Atrial and Ventricular arrhythmias
  • New Oral Anticoagulants (NOACS)
  • Hypertension: Approach to Achieving Guideline Defined Targets
  • Pharmacological Consideration in the CV Patient with Kidney Disease
  • Heart Failure:  The Complexities of Heart Failure Management
  • Diuretics
  • Medication Safety / Medication Reconciliation

Learning Objectives: 
Upon completion of this course, the participant will be able to:

Session 1

  1. Compare pharmacologic treatment options for the short term and long-term treatment of STEMI, NSTE-ACS and stable coronary artery disease.
  2. Contrast the use of fibrinolytics, anticoagulants and antiplatelet therapy in patients with CAD.
  3. Contrast the impact of various lipid lowering agents in achieving guideline recommended lipid goals.
  4. Identify strategies for lipid management in the patient experiencing statin intolerance.
  5. Examine pharmacologic treatment strategy options with oral diabetic agents in the CV patient with type II diabetes.
  6. Determine the appropriate use of SGLT inhibitors in reducing cardiovascular risk in the patient with diabetes.
  7. Evaluate medication driven treatment strategy plans for tobacco cessation.
  8. Compare pharmacotherapy options for the treatment of PAD.
  9. Develop strategies to improve patient medication adherence through an understanding of patient barriers.

Session 2

  1. Differentiate risk /benefits of antiarrhythmics medications based on Vaughan Williams classification.
  2. Contrast the pharmacologic treatment options for AF with a rate control versus a rhythm control strategy.
  3. Examine the appropriateness of the new oral anticoagulants for stroke prevention in AF. 
  4. Utilizing evidence-based (EB) guidelines, develop a systematic approach to the assessment and treatment of hypertension.
  5. Integrate concepts of acute kidney injury failure and chronic kidney disease into pharmacologic treatment strategies.
  6. Discuss EB pharmacologic treatment strategies for HFrEF and HFpEF.
  7. Prioritize the use of EB medications during periods of decompensated heart failure.
  8. Outline strategies for initiation and up titration of medications in patients with heart failure.
  9. Determine practice changes that could improve patient safety with medication reconciliation.

Continuing Education:
14.5 hours of continuing education will be offered with this program.  All 14.5 hours are approved as pharmacology continuing education that meets criteria for advanced practice nurses who cares for adult patients. CNEA is a provider approved by the California Board of Registered Nursing, provider number 15714.

This course is no longer available for purchase.

You have purchased this previously, or already have it in your cart.

Return to Cart